Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets

A Peter Thiel-backed transatlantic startup that once branded itself as an “anti-CRO” is pivoting from a clinical trials operator to a drug developer. Lindus Therapeutics is betting that its experience over ...